Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds Vivasrespiratory-sleep-and-airway

Paeds Vivas · respiratory-sleep-and-airway

Narcolepsy and hypersomnolence — branching viva

Branching viva from a school-aged child with new excessive daytime sleepiness and emotion-triggered loss of muscle tone, through the recognition of cataplexy and narcolepsy type 1, the mechanism of orexin neuron loss, the confirmatory polysomnography, multiple sleep latency test and cerebrospinal fluid orexin, the layered management of sleepiness and cataplexy, and a pivot to an adolescent with sleepiness but no cataplexy in whom secondary and idiopathic hypersomnolence must be excluded.

branching clinical structured oral2 min readVerification in progress

Target exams

RACP General PaediatricsRACP DCEMRCPCH ClinicalRCPSC Pediatrics
On this page
Study tools

Target exams

RACP General PaediatricsRACP DCEMRCPCH ClinicalRCPSC Pediatrics
Prompt
You are the paediatric registrar in a general and sleep clinic. The examiner asks you to work through a ten-year-old with three months of irresistible daytime sleepiness who loses muscle tone in the head and knees when he laughs, and later an adolescent with excessive daytime sleepiness but no cataplexy. Information is released in stages.

Opening — framing the problem

The examiner begins: a ten-year-old has three months of irresistible daytime sleepiness and, when he laughs hard, his knees buckle and his head drops while he stays fully aware. Talk me through your reasoning. [1] [2]

I would frame this as narcolepsy type 1 until proven otherwise, because the pairing of new, irresistible daytime sleepiness with emotion-triggered loss of muscle tone and preserved consciousness is the clinical signature of cataplexy, which is nearly specific for narcolepsy type 1. The rapid weight gain points to the hypothalamic involvement seen in paediatric narcolepsy. [2] [7]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References14ShowHide
  1. [1]Morse AM; Kim SY; Harris S; et al Narcolepsy: Beyond the Classic Pentad. CNS Drugs, 2025.PMID 40111737
  2. [2]Rocca FL; Pizza F; Ricci E; et al Narcolepsy during Childhood: An Update. Neuropediatrics, 2015.PMID 25961600
  3. [3]Barateau L; Pizza F; Chenini S; et al Narcolepsies, update in 2023. Rev Neurol (Paris), 2023.PMID 37634997
  4. [4]Rauf R; Asif S; AlSaafeen A; et al Orexin Deficiency in Narcolepsy: Molecular Mechanisms, Clinical Phenotypes, and Emerging Therapeutic Frontiers. Brain Behav, 2025.PMID 41076550
  5. [5]Vassalli A; Tafti M; Liblau RS Narcolepsy is (not) an autoimmune disease. Nat Rev Neurol, 2026.PMID 42321519
  6. [6]Ding WT; Gao JY; Guo ZL; et al Research Progress in the Roles of Influenza A H1N1 Virus and Its Vaccine in the Pathogenesis of Narcolepsy Type 1. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 2025.PMID 41503654
  7. [7]Poli F; Pizza F; Mignot E; et al High prevalence of precocious puberty and obesity in childhood narcolepsy with cataplexy. Sleep, 2013.PMID 23372264
  8. [8]Dhanju S; Al-Saleh S; Amin R; et al A retrospective analysis of clinical characteristics of childhood narcolepsy. Paediatr Child Health, 2018.PMID 30455579
  9. [9]Pillen S; Pizza F; Dhondt K; et al Cataplexy and Its Mimics: Clinical Recognition and Management. Curr Treat Options Neurol, 2017.PMID 28478511
  10. [10]Biscarini F; Vandi S; Zenesini C; et al Use of Portable 24-Hour Polysomnography as Alternative Diagnostic Tool for Narcolepsy Type 1 in Adults and Children. Neurology, 2025.PMID 40080737
  11. [11]Tang SH; Min J; Zhang X; et al Incidence of pediatric narcolepsy diagnosis and management: evidence from claims data. J Clin Sleep Med, 2024.PMID 38450539
  12. [12]Keam SJ Pitolisant: Pediatric First Approval. Paediatr Drugs, 2023.PMID 37233887
  13. [13]Moresco M; Pizza F; Antelmi E; et al Sodium Oxybate Treatment in Pediatric Type 1 Narcolepsy. Curr Drug Metab, 2018.PMID 29512449
  14. [14]Dauvilliers Y; Lammers GJ; Lecendreux M; et al Effect of sodium oxybate on body mass index in pediatric patients with narcolepsy. J Clin Sleep Med, 2024.PMID 37942930
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousLaryngomalacia, tracheomalacia and vocal-cord dysfunction: Vivarespiratory-sleep-and-airwayNextNeuromuscular respiratory failure and airway clearance — branching vivarespiratory-sleep-and-airway